Microglia positively affect neural progenitor cell physiology through the release of inflammatory mediators or trophic factors. We previously demonstrated that reactive microglia foster K ATP -channel expression, and that blocking this channel using glibenclamide administration enhances striatal neurogenesis after stroke. In the present study, we investigated whether the microglial K ATP -channel directly influences the activation of neural precursor cells from the subventricular zone by using transgenic Csf1r-GFP mice. In vitro exposure of neural precursor cells to lipopolysaccharide and interferon-gamma resulted in a significant decrease in precursor cell number. The complete removal of microglia from the culture or exposure to enriched microglia culture also decreased the precursor cell number.
Introduction
Adult neurogenesis is a multistep process involving the proliferation of neural precursor cells (NPCs), their differentiation into lineage-restricted immature neurons, and their progressive maturation into fully functional and integrated neurons. There is a constant turnover of neurons in the two niches of the adult brain necessary for the maintenance of specific functions and ongoing brain plasticity, namely the subgranular zone of the hippocampus and the subventricular zone (SVZ) of the lateral ventricle (Merkle et al. 2007; Toni et al. 2007 ).
Microglia are the primary immune effector cells in the brain that release soluble factors promoting the proliferation, migration and differentiation of NPCs (Aarum et al. 2003; Deierborg et al. 2010; Walton et al. 2006) . When microglia become reactive in response to injury, they are generally considered to be anti-neurogenic, as they release proinflammatory cytokines; however, under inflammatory conditions, they have been shown to be neuroprotective (Carson et al. 2006) and to enhance neurogenesis (Ekdahl et al. 2009 ). It is therefore likely that the microglial activity state depends on the balance of secreted molecules within the microenvironment (Perry et al. 2010 ).
The sulphonylurea receptor 1 (SUR1) subunit can assemble either with the inward rectifying K + ion channel subunits Kir6.1 or Kir6.2 to form the K ATP -channel (Mikhailov et al. 2005) or with the transient receptor potential melastatin (Trpm4) to form the NC Ca-ATPchannel (Simard et al. 2012 ). SUR1-regulated channels have been shown to be expressed in neurons, astrocytes, oligodendrocytes and endothelial cells under ischemic conditions (Simard et al. 2006; Simard et al. 2012) . We recently demonstrated that reactive microglia increased the expression of SUR1 and the K ATP -channel after cerebral ischemia or after a proinflammatory stimuli (Ortega et al. 2012 . Indeed, this and other in vitro studies have demonstrated that the K ATP -channel regulates the cell reactive state, controls the release of a diversity of inflammatory mediators, such as nitric oxide, interleukin-6 (IL-6) and NPC activity, fresh glibenclamide solution, ranging from fM to µM in concentration, was added directly to the culture medium upon plating.
Differentiation of primary neurospheres
Neurospheres established from the SVZ were plated onto glass coverslips coated with poly-L-ornithine (Sigma) and laminin (natural mouse; Invitrogen) before being cultured in neurosphere differentiation medium containing mouse NeuroCult NSC basal medium, 10%
mouse NeuroCult NSC proliferation supplements, and 100 U/ml penicillin/streptomycin (Invitrogen) . To quantitatively analyze the multipotentiality of the neurospheres, individual neurospheres were selected from cultures and were allowed to differentiate for 6 days before analysis of differentiation markers by immunohistochemistry.
Immuncytochemistry. Coverslips containing the differentiated neurospheres were rinsed gently with PBS and fixed with 4% paraformaldehyde (PFA) for 15 min at 4ºC. Fixed samples were for immunocytochemistry, as described previously (Vukovic et al. 2012 ).
Briefly, samples were blocked (5% FCS and 5% normal goat serum in PBS containing 0.1% 
Fluorescence-activated cell sorting and generation of primary neurosphere culture
To either deplete or collect microglia from SVZ cultures, dissociated cells from Csf1r-GFP transgenic mice were sorted using a FACS Vantage SE DiVa sorter (BD Bioscience). Four to six SVZs were used per preparation to obtain a single-cell suspension, as described above.
Snapshots of GFP pos SVZ microglia were obtained using AMNIS ImageStream 100. To assess the effect of glibenclamide on neurosphere cultures in either the presence or absence of microglial cells, we used three different approaches: (1) GFP pos cells (microglia) were removed from the cell culture (microglia-depleted cultures; -MO) and plated in 200 µl/well of complete neurosphere medium (~5,000 events/well or ~16,000 events/cm 2 ); (2) the control SVZ preparations were passed through the cell sorter and all cell populations were collected (containing ~10% of microglial cells; +MO) and plated in 200 µl/well of complete medium (~16,000 events/cm 2 ); (3) Enriched microglial cultured was obtained by combination of control SVZ preparations (~16,000 events/cm 2 ) plated in 100 µl/well of complete medium with 100 µl of the GFP pos cells (~16,000 events/cm 2 ) derived from cortical samples. Primary neurospheres were incubated for 7 days to permit neurosphere formation and the number and size of the SVZ neurospheres were measured.
Activation and treatment of fluorescence-activated cell sorting cultures. To characterize whether blockade of the microglial K ATP -channel instructs SVZ neurogenesis, we performed primary neurosphere cultures either in the presence (+MO) or absence (-MO) of microglia, or, alternatively, in an environment with an increased number of microglia. Cultures were activated using 0.1 µg/mL recombinant lipopolysaccharide (LPS, Sigma-Aldrich) and 0.05 ng/mL recombinant mouse interferon gamma (IFNγ; R&D), both of which were diluted in complete culture media. At the same time, all cultures were co-treated with fresh glibenclamide solution diluted in complete culture media and added until the desired final concentration was achieved (DMSO final concentration <0.05%).
MHCII staining. To assess microglial activation, MHCII-positive cells were quantified, analyzed, and sorted using FACS. In brief, cells were incubated with unconjugated rat anti-CD16/32 (1:100; BD PharMingen) for 5 min at RT, followed by incubation with anti-I-A/I-E antibody (1:200) for 15 min at RT. The cells were washed once in fresh medium before analysis and/or FACS.
Microglial-conditioned media and generation of primary neurosphere culture
To obtain the microglial-conditioned media, cortical GFP pos cells were collected (n = 4 to 6) by cell sorting, as described above, and harvested in 15 mL Falcon™ tubes to a final concentration of 100,000 cells/mL. FACS-isolated GFP pos -microglia were cultured for 24 h in the presence of either LPS+IFNγ, glibenclamide (K ATP -channel blocker) or diazoxide (K ATPchannel opener), all of which were diluted in complete culture media until the desired final concentration was achieved (DMSO final concentration <0.05%). Diazoxide was added at a concentration of 50 µM (Virgili et al. 2011) either alone or in combination with glibenclamide. Following centrifugation at 100 g for 15 min, we collected the microglialconditioned media to perform the neurosphere assay, as described above. Aliquots of conditioned media were kept at -20°C to determine the concentration of soluble cytokine/chemokine. Primary neurosphere cultures in the presence of microglial-conditioned media were incubated for 7 days in humidified 5% CO 2 to allow neurosphere formation.
After incubation, the number and size of the neurospheres were measured. 
Primary glial cultures

GLIA
Primary glial cultures were obtained as described previously (Saura et al. 2003b ). Mixed glial cultures from 2 to 4-day-old C57BL/6 mice were obtained from the cerebral cortex (n = 6 to 8) and digested using 0.25% trypsin-EDTA solution (Invitrogen) for 30 min at 37ºC. To assess the effect of astrocytes on neurospheres, half of the wells were processed as mixed glial cultures (~250,000 cells/cm 2 ) and half were sorted to obtain pure-microglial cultures using the mild trypsinization method after 19-21 DIV, as described by Saura and colleagues (2003b) . After the astroglial layer was removed, microglia were cultured for 24 h in complete medium. To assess the purity of the microglial culture, cells were fixed with 4%
PFA for 15 min at 4ºC and immunocytochemistry was carried out with an anti-Iba1 (ionized calcium binding adaptor molecule 1; 1:500; Wako Chemical) primary antibody and a goat anti-mouse Alexa Fluor-488 secondary antibody (1:500; Molecular Probes). The purity of the cultures was 98±1% (n = 5 cultures), based on the number of Iba1-positive cells (~20,000
Iba1-positive cells/cm 2 ).
Activation of primary glial cultures. Primary mixed glial or primary microglial cultures were activated for 24 h in the presence of LPS+IFNγ. At the same time, cultures were cotreated for 24 h with fresh glibenclamide or diazoxide solution, as described above.
Immuncytochemistry to detect the K ATP -channel. To assess the expression of the K ATPchannel in the pure microglia, immunocytochemistry was carried out on 4% PFA fixed cells with a rat anti-CD68 antibody (1:500; Abcam) combined with a goat anti-SUR1 (1/100; Santa Cruz), rabbit anti-Kir6.1 or anti-Kir6.2 (1/400; Alomone Labs) primary antibodies. As secondary antibodies, we used goat anti-rat Alexa Fluor-488 and anti-rabbit/goat Alexa Fluor-488 (1:500; Molecular Probes).
Neuronal Culture
We used embryonic neuronal cultures to determine whether glibenclamide influenced NPC survival. Hippocampi from E16 to E18 C57BL/6 mice were isolated (n = 6 to 8), minced and digested using 0.05% trypsin-EDTA solution (Invitrogen) for 15 min at 37ºC. Digestion was halted by adding an equal volume of trypsin-inhibitor (Invitrogen) and spinning the solution for 5 min at 104 g. The cell pellet was then suspended in 1 ml DMEM:F12 media (Gibco), and cells were passed through a 19-gauge needle and then a 23-gauge needle. The cell suspension was filtered through a mesh 40 µM in diameter before being diluted in complete culture media containing glibenclamide. Cells were plated onto glass coverslips previously coated with poly-L-ornithine (Sigma) to a final density of 100,000 cells/well. Culture media supplemented with glibenclamide was changed after 24 h. Immunofluorescence was carried out after 7 DIV to detect β-III tubulin-and DCX-positive cells as described above. To count the number of β-III tubulin and DCX-expressing cells, five random pictures/well were taken using a Zeiss inverted microscope, and images were analyzed using ImageJ 1.39u (NIH, USA).
Cytometric Bead Array (CBA)
To quantify the concentration of releasing cytokines in the conditioned media derived from the pure primary microglia cultures, IL-6, TNFα, IL-12p70, IFNγ and CCL2 were assayed using the cytometric bead array (CBA) reagents (BD Biosciences) with four-color FACS of BD CBA data was performed using the FCAP array software provided by the manufacturer (BD Bioscience).
Statistical analysis
Data were subjected to statistical analysis using the GraphPad Prism software (version 5.0c).
All experiments were subjected to statistical analyses using a one-way ANOVA followed by the Bonferroni post hoc test for pair wise group comparisons. Values are presented as mean ± standard error of the mean (SEM), with significance determined at p<0.05.
Results
Microglial K ATP -channel blockade restores neural precursor cell activation after inflammation
Using the Csf1r-GFP transgenic mouse, we selectively isolated microglia using fluorescence- We evaluated the influence of microglial activation on NPC activity by assessing the neurosphere formation frequency in the presence or absence of microglia. After SVZ cultures containing ~10% microglia (+MO) were treated with LPS+IFNγ, NPC number was significantly reduced, by 35.4±8%, which was in agreement with our previous findings (Li et al. 2010 ) ( Figure 1D and E). A further significant decrease in neurosphere number was observed in cultures depleted of microglia (-MO) (49.2±6%; p<0.05 when compared to +MO). It therefore appeared probable that the presence of microglia at endogenous levels was protective of neurosphere formation. To create a similar situation to that seen after brain injury, where microglia are present in greater concentrations, a higher ratio (1:1) of GFP pos (microglia) to GFP neg cells was added to the SVZ neurosphere culture. After
LPS+IFNγ treatment, the formation of neurospheres from microglial-enriched cultures was significantly reduced (75.6±8%; p<0.05 and p<0.01 when compared to -MO and +MO, respectively), indicating that an environment with enriched microglia negatively affects NPC activation. When the K ATP -channel blocker glibenclamide (1 pM and 1 nM) was added to the enriched microglial culture, we were able to almost completely overcome the inhibitory effect of LPS+IFNγ treatment. In the presence of 1 nM glibenclamide there was no difference between the three conditions treated with LPS+IFNγ. Our data indicate a trend toward improved recovery with increasing concentrations of glibenclamide.
Microglia release a soluble factor to enhance neurogenesis
As glibenclamide positively influences NPC formation in situations of increased microglial concentration, we first checked whether primary microglia expressed the K ATP -channel. We performed double immunolabeling using anti-SUR1, anti-Kir6.1 and anti-Kir6.2 antibodies combined with anti-CD68 antibody as microglia/macrophage marker (Figure 2A) .
Colocalization of Kir6.1, Kir6.2 and SUR2 with CD68 labeling indicated that non-activated microglia (control, left panel) and also activated microglia (LPS+IFNγ, right panel) expressed the K ATP -channel, making these cells a putative target for glibenclamide in vitro.
We then looked at whether soluble factors had a direct effect on neurosphere formation and size. Conditioned media from isolated GFP pos cells treated with LPS+IFNγ for 24 h significantly reduced the number of neurospheres when added to neurosphere cultures by 22.2±3% (p<0.01) ( Figure 2B ). Conversely, cultures treated with LPS+IFNγ and 1 pM or 1 nM glibenclamide produced significantly more neurospheres (11.4±3% and 10.3±3%
respectively; p<0.01 in both cases) than the cultures treated with LPS+IFNγ alone. The opposite effect was observed when the K ATP -channel opener diazoxide was used alone (23.8±5%; p<0.05 compared to glibenclamide 1 nM). Diazoxide partially reversed the effect of glibenclamide; however, this reduction was not significant. These data suggest that glibenclamide treatment triggers microglia to release soluble neurogenesis-promoting factors.
Conditioned media from microglial cultures treated with LPS+IFNγ caused an overall reduction in neurosphere diameter, irrespective of whether or not they had received glibenclamide treatment (p<0.01, Figure 2C ). Neuronal differentiation was almost completely inhibited when neurospheres were cultured with conditioned media from microglia treated with LPS+IFNγ, with only a few β-III tubulin-positive cells observed (data not shown). It therefore appears that long-term exposure to pro-inflammatory signals blocks neuronal differentiation.
Neural precursor cell activation is microglia-dependent
To study whether the effect of glibenclamide was mediated soley by microglia, or whether other cells, such as astrocytes, could also be implicated in the process, we used primary mixed glial cultures (microglia and other cell types) and pure microglial cultures, both treated with LPS+IFNγ and glibenclamide for 48 h. Mixed glial cultures showed both GFAP-and Iba1-positive cells (75%±2 for GFAP, 20%±2 for Iba1 and 5%±1 for others), whereas >98±1% of cells in pure microglial cultures were positive only for Iba1 ( Figure 3A) . Visual analysis of cell morphology showed that, compared to control conditions, LPS+IFNγ treatment resulted in astrocytes with a greater number of wider processes and an extended cytoplasm, and microglia with a classical amoeboid shape ( Figure 3A , right vs center and left panels). Cell morphology was not affected by glibenclamide ( Figure 3A , right panels).
Neurosphere cultures treated with conditioned supernatant from mixed glial cultures challenged with LPS+IFNγ showed a 75±3% reduction in neurosphere formation frequency compared to control (p<0.001; Figure 3B ). This effect could not be rescued by treatment with either glibenclamide or diazoxide alone, nor in combination (p<0.001 compared to control 
K ATP -channel modulates the release of microglial inflammatory factors
Having established a critical role for microglia in mediating the beneficial effects of K ATPchannel blockade after inflammatory conditions, we next sought to unravel the underlying molecular mechanism by which microglia regulate NPC activation under inflammatory conditions. To do so, we tested a panel of cytokines/chemokines that affect NPC physiology and found that supernatant from primary pure microglial cultures treated with LPS+IFNγ showed an overall increase in concentrations of TNFα, IL-6 and CCL2 (p<0.001; Figure 4 ).
Detailed post hoc analysis indicated that diazoxide induced an anti-inflammatory response and decreased production of TNFα, IL6 and CCL2 (p<0.001 or p<0.01 compared to LPS+IFNγ), whereas glibenclamide treatment enhanced microglial production of CCL2 (p<0.05 compared to LPS+IFNγ) had no observable effect on IL10 or IL12p70 (data not shown). These results indicate that the microglial K ATP -channel mediates the release of cytokines/chemokines or other neurotrophic factors that can modulate neurogenesis.
K ATP signaling does not stimulate precursor activation under physiological conditions
We next wanted to elucidate whether neurosphere formation under physiological conditions is affected by glibenclamide as observed under inflammatory conditions. We treated SVZderived neurosphere cultures (containing ~10% microglia) with glibenclamide or diazoxide and found that neither neurosphere number ( Figure 5A ) nor size ( Figure 5B ) were affected. We also assessed whether glibenclamide affected NPC differentiation, and found that in the presence of resting microglia, the total number of neurospheres containing either 
Discussion
It has been suggested that immunological control of neural stem cell physiology and the dual role of microglia is paramount in mediating neurogenesis after brain injury. In the present study we explored whether the microglial K ATP -channel influences adult NPC activity under pro-inflammatory conditions. We used a novel ex vivo model system using Csf1r-GFP transgenic mice, as described by Vukovic and colleagues (2012) , whereby microglia could be selectively depleted or isolated and subsequently added to neurosphere cultures. We were able to show that blockade of the microglial K ATP -channel restored the reduction in NPC number normally observed after inflammation and that this recovery was a consequence of the release of soluble factors.
The K ATP -channel has a key role in the degree of microglial-derived inflammation
After brain injury, reactive microglia present a variety of phenotypes that each influence NPC physiology and neurogenic processes in different ways (Kettenmann et al. 2011) . Systemic or central administration of LPS is a common method to activate microglia, as well an inflammatory response, and LPS-activated microglia and its conditioned medium has been shown to reduce neural stem cells survival and inhibit neural differentiation in vitro (Cacci et al., 2008; Monje et al., 2003) . Thus, we used LPS+IFNγ to activate microglia, which in turn caused a reduction in NPC activation and neuronal differentiation. Interestingly, high inhibition of NPC activation was seen as a result of exposure to cultures with enriched concentrations of microglia, most likely due to an excessive production of pro-inflammatory mediators, which are detrimental for NPC proliferation. Similar findings were described by Picard-Riera and colleagues (2002) who observed that an exacerbated inflammatory response is complicated, strengthening the inhibition of NPC proliferation, stimulating migration, and enhancing astro-or oligodendrogenesis (Picard-Riera et al. 2002) . Our results using conditioned media derived from the primary microglial culture (>98% purity) or pure isolated GFP pos -microglia (100% purity) also point toward activated microglia exerting the observed effect. Our data confirm that neurogenesis is a microglial-dependent process, where microglia are required for NPC activation, and uncontrolled microgliosis is detrimental for neurogenesis.
Microglial K ATP -channel blockade fosters neural precursor cell activation through a soluble factor
Microglia have positive and negative regulatory effects as constituents of the neurogenic niche (Morrens et al., 2012) . In the pathogenic brain, microglia produce trophic factors with a positive effect on neurogenesis (Butovsky et al. 2006) . As LPS+IFNγ does not enhance microglial proliferation in vitro (Kloss et al. 1997; Palwinder et al. 2006) , and after a brain insult, microglia proliferate and migrate from the surrounding tissue towards the site of injury, increasing their cell density in the affected area, we used enriched microglial cultures to resemble this inflammatory situation. Given that in our neurosphere cultures, approximately 10% of the cells are microglia (Vukovic et al. 2012 ) and that conditioned media from primary reactive microglia treated with glibenclamide and microglial enriched cultures reversed the inhibition of neurogenesis caused by LPS+IFNγ treatment, it seems that at least a certain number of microglial cells is necessary to respond to glibenclamide and produce enough trophic factors to reverse the inhibition of neurogenesis. Thus, by controlling the reactive phenotype of reactive microglia through the blockade of the K ATP -channel, we were able to restore neurogenesis through a process that did not require cell-cell contact.
Walton and colleagues (2006) however, it can enhance NPC differentiation (Turbic et al. 2011; Liu et al. 2007 ). Our previous findings in vivo demonstrate that glibenclamide increased migration of doublecortin-positive striatal cells toward the lesion after cerebral ischemia ), where MCP-1 has a major role. The enhanced NPC activation observed in the current study is unlikely to be a consequence of MCP-1 action alone and further cytokine analysis is necessary to reveal the mechanism by which the microglial K ATP -channel blockade enhances NPC activation.
As glibenclamide binds to SUR1, which forms both the K ATP -channel and the astroglial NC Ca-ATP -channel expressed under pathological conditions (Ortega et al. 2012; Ortega et al. 2013; Simard et al. 2006) , we wanted to further explore the relationship between enhanced neurogenesis and the microglial K ATP -channel and the astroglial NC Ca-ATP -channel.
We found that conditioned media from mixed glial cultures markedly blocked NPC activation, an effect that could not be rescued by glibenclamide treatment. These results are in line with studies using experimental cerebral ischemia models, where the NC Ca-ATP channel was involved in the resolution of the cytotoxic edema (Simard et al. 2006; Simard et al. 2012 ). It appears that the astroglial NC Ca-ATP channel, although capable of reversing the cytotoxic edema after ischemia, does not contribute to the glibenclamide-dependent rescue of neurogenesis . Also, as more proliferative microglia were present in mixed glial cultures than in microglial cultures, it is therefore possible that astrocytes in mixed glial cultures use a positive feedback mechanisms to strengthen the pro-inflammatory response derived from microglia (Losciuto et al, 2013; Saura et al. 2003a ). Indeed, NPC inhibition could be a consequence of an excessive production of pro-inflammatory factors mediated by microglia; however, as reactive microglia express the K ATP -channel (Ortega et al. 2012; Ortega et al. 2013 ), a glibenclamide-derived response would have also been expected in this scenario.
Treatment of microglia with diazoxide does not correlate with enhanced precursor cell activation in vitro
Previous studies established a pro-neurogenic role for microglia in both the SVZ and subgranular zone (Mcpherson et al. 2011; Thored et al. 2009 ). In our study, microglialconditioned supernatant treated with diazoxide, a well-known anti-inflammatory K ATPchannel opener (Virgili et al. 2011; Zhou et al. 2008) , presented a lower concentration of inflammatory mediators but did not foster NPC activation. Our results align with previous studies showing that anti-inflammatory minocycline treatment, does not cause any changes in neurogenesis (Ng et al., 2012) , or lead to a reduction in NPC proliferation of SVZ progenitors after inflammation (Kim et al. 2009; Deierborg et al., 2010) . On the contrary, although glibenclamide did not modify the release of IL-6 and TNFα, it was able to enhance activation of NPCs. Thus, rather than modifying the microglial inflammatory phenotype, the glibenclamide effect most likely resulted from the modification of the release of specific proneurogenic factors. Studies of the specific role of inflammatory cytokines have shown conflicting results in central nervous system pathogenesis and neurogenesis, supporting the view that the effects of inflammatory cytokines are dose-and context-dependent (Bernardino et al. 2008; Bowen et al. 2011; Lambertsen et al. 2009; Veroni et al. 2010 ). In addition, the finding that cyclooxigenase-2 inhibitors, which are highly expressed by reactive microglia, are potent suppressors of neurogenesis (Goncalves et al., 2010) indicates that anti-inflammatory therapies may not all be beneficial for restoring neurogenesis. Our findings reinforce the idea that some pro-inflammatory modulators, such as IL-6 and TNFα, do not act (D) An overall reduction in neurosphere number was observed after LPS+IFNγ (L+I) treatment in all conditions when compared to control (p<0.01; n = 3 to 4 per experimental condition). Glibenclamide (Gbc) reversed the inhibitory effect of the enriched microglial culture in a dose-dependent manner. (E) Representative image of SVZ neurospheres. (Results are shown as mean ± SEM; one-way ANOVA followed by the Bonferroni post hoc test; *p<0.05 and **p<0.01; scale bar in E = 150 µm, and E insert = 50 µm).
157x249mm (300 x 300 DPI) Figure 2 . Microglia express the KATP-channel and modulate neurogenesis through a soluble factor. (A) Representative photomicrographs of pure microglial culture in control conditions (left panel) or after 24 h of activation with LPS+IFNγ (right panel). The KATP-channel components Kir6.1, Kir6.2 and SUR1 (red) were colocalized with microglial cells CD68 (green), and counterstained with DAPI (blue). The GFPpos cell population was collected from Csf1r-GFP transgenic mice by cell sorting and cultured for 24 h in the presence of LPS+IFNγ (L+I), glibenclamide (Gbc) and/or diazoxide (Dz). The conditioned-media from these cells was then used to perform neurosphere cultures. (B) Conditioned media of microglia treated with glibenclamide was able to restore the inhibition of neurosphere formation caused by L+I (p<0.01 at 1 pM and 1 nM Gbc). Diazoxide reversed this effect (p<0.05 compared to Gbc 1 nM). At 1 nM glibenclamide, this reduction was not significant (n = 3 to 7 per experimental condition). Dotted line represents control group. (C) Overall reduction in neurosphere size after treatment with L+I. Glibenclamide treatment did not affect neurosphere size (n = 5-7 per experimental condition). (Results are shown as mean ± SEM; one-way ANOVA followed by the Bonferroni post hoc test; *p<0.05 and **p<0.01; scale bar = 20 µm). 199x199mm (300 x 300 DPI) Figure 3 . Absence of astrocytes increased neural precursor cell activation. (A) Representative photomicrographs of mixed glial or pure microglial culture after 24 h of LPS+IFNγ (L+I) and glibenclamide (Gbc; 1 pM) treatment. Microglial cells were immunostained for Iba1 (green), astrocytes for GFAP (red), and counterstained with DAPI (blue). (B) Cultures treated with conditioned supernatant from mixed glial cultures challenged with LPS+IFNγ showed a 75±3% reduction in neurosphere formation frequency, while those treated with supernatant derived from pure microglial cultures and LPS+IFNγ showed a 45.3±8% decrease (p<0.001 compared to control in both cases). Conditioned media from microglial cultures treated with 1 pM glibenclamide restored neurosphere formation in pure microglial cultures to near control levels. This positive effect was blocked by diazoxide alone and when combined with glibenclamide (p<0.001 compared to control in both cases; n = 5 per experimental condition). Values are given as mean ± SEM. For pairwise group comparisons, a one-way ANOVA followed by the Bonferroni post hoc test was used. ***p<0.001 (vs control conditions), ##p<0.01, ###p<0.001 (vs pure microglia cultures). Dotted line in B represents control group = 100%. Scale bar = 50 µm. 155x180mm (300 x 300 DPI) Figure 4 . Microglial KATP channel blockade increased the production of the MCP-1 (A) The concentration of microglial-released cytokines and inflammatory mediators from primary pure microglial-conditioned media as a result of treatment with LPS+IFNγ (L+I), glibenclamide (Gbc; KATP-channel blocker) and/or diazoxide (Dz; KATP-channel opener) was quantified (n = 4 per experimental condition). LPS+IFNγ treatment increased the overall production of IL-6, TNFα and MCP-1 (p<0.001) and the addition of diazoxide reversed this effect. Glibenclamide at 1 pM boosted the production of MCP-1 when compared to LPS+IFNγ and 1 nM glibenclamide. Values are given as mean ± SEM. For pairwise group comparisons, a one-way ANOVA followed by the Bonferroni post hoc test was used. *p<0.05, **p<0.01, ***p<0.001. 49x16mm (300 x 300 DPI)
